271 related articles for article (PubMed ID: 32673664)
1. Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis.
Mounier NM; Abdel-Maged AE; Wahdan SA; Gad AM; Azab SS
Life Sci; 2020 Oct; 258():118071. PubMed ID: 32673664
[TBL] [Abstract][Full Text] [Related]
2. The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment ("chemobrain") involving TNF-α.
Ren X; Keeney JTR; Miriyala S; Noel T; Powell DK; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Free Radic Biol Med; 2019 Apr; 134():1-8. PubMed ID: 30593843
[TBL] [Abstract][Full Text] [Related]
3. An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.
Das A; Ranadive N; Kinra M; Nampoothiri M; Arora D; Mudgal J
Curr Neuropharmacol; 2020; 18(9):838-851. PubMed ID: 32091339
[TBL] [Abstract][Full Text] [Related]
4. Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment ("chemobrain"), a condition that significantly impairs the quality of life of many cancer survivors.
Ren X; Boriero D; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1088-1097. PubMed ID: 30759363
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of cytokine mediated chemotherapy induced cognitive impairment.
Ren X; St Clair DK; Butterfield DA
Pharmacol Res; 2017 Mar; 117():267-273. PubMed ID: 28063894
[TBL] [Abstract][Full Text] [Related]
6. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
Butterfield DA
Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 Signaling Pathway: a Potential Therapeutic Target in Combating Oxidative Stress and Neurotoxicity in Chemotherapy-Induced Cognitive Impairment.
Lal R; Dharavath RN; Chopra K
Mol Neurobiol; 2024 Feb; 61(2):593-608. PubMed ID: 37644279
[TBL] [Abstract][Full Text] [Related]
8. Neuroimmune reactivity marker expression in rodent models of chemotherapy-induced cognitive impairment: A systematic scoping review.
George RP; Semendric I; Hutchinson MR; Whittaker AL
Brain Behav Immun; 2021 May; 94():392-409. PubMed ID: 33516919
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of anti-inflammatory agents in reducing chemotherapy-induced cognitive impairment in preclinical models - A systematic review.
Haller OJ; Semendric I; George RP; Collins-Praino LE; Whittaker AL
Neurosci Biobehav Rev; 2023 May; 148():105120. PubMed ID: 36906244
[TBL] [Abstract][Full Text] [Related]
10. PAN-811 prevents chemotherapy-induced cognitive impairment and preserves neurogenesis in the hippocampus of adult rats.
Jiang ZG; Winocur G; Wojtowicz JM; Shevtsova O; Fuller S; Ghanbari HA
PLoS One; 2018; 13(1):e0191866. PubMed ID: 29370277
[TBL] [Abstract][Full Text] [Related]
11. The cancer chemotherapeutic agent paclitaxel (Taxol) reduces hippocampal neurogenesis via down-regulation of vesicular zinc.
Lee BE; Choi BY; Hong DK; Kim JH; Lee SH; Kho AR; Kim H; Choi HC; Suh SW
Sci Rep; 2017 Sep; 7(1):11667. PubMed ID: 28916767
[TBL] [Abstract][Full Text] [Related]
12. Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits.
Orchard TS; Gaudier-Diaz MM; Weinhold KR; Courtney DeVries A
Breast Cancer Res Treat; 2017 Feb; 161(3):391-398. PubMed ID: 27933449
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNFα.
Rummel NG; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Cell Mol Life Sci; 2021 Oct; 78(19-20):6533-6540. PubMed ID: 34424346
[TBL] [Abstract][Full Text] [Related]
14. The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment.
Subramaniam CB; Bowen JM; Gladman MA; Lustberg MB; Mayo SJ; Wardill HR
Neurosci Biobehav Rev; 2020 Sep; 116():470-479. PubMed ID: 32681936
[TBL] [Abstract][Full Text] [Related]
15. Animal models of chemotherapy-induced cognitive decline in preclinical drug development.
John J; Kinra M; Mudgal J; Viswanatha GL; Nandakumar K
Psychopharmacology (Berl); 2021 Nov; 238(11):3025-3053. PubMed ID: 34643772
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.
Ma J; Huo X; Jarpe MB; Kavelaars A; Heijnen CJ
Acta Neuropathol Commun; 2018 Oct; 6(1):103. PubMed ID: 30270813
[TBL] [Abstract][Full Text] [Related]
17. The Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-"Chemobrain".
Gaman AM; Uzoni A; Popa-Wagner A; Andrei A; Petcu EB
Aging Dis; 2016 May; 7(3):307-17. PubMed ID: 27330845
[TBL] [Abstract][Full Text] [Related]
18. Neurobiological Mechanisms of Chemotherapy-induced Cognitive Impairment in a Transgenic Model of Breast Cancer.
Winocur G; Berman H; Nguyen M; Binns MA; Henkelman M; van Eede M; Piquette-Miller M; Sekeres MJ; Wojtowicz JM; Yu J; Zhang H; Tannock IF
Neuroscience; 2018 Jan; 369():51-65. PubMed ID: 29113931
[TBL] [Abstract][Full Text] [Related]
19. Oroxylum Indicum ameliorates chemotherapy induced cognitive impairment.
Pondugula SR; Majrashi M; Almaghrabi M; Ramesh S; Abbott KL; Govindarajulu M; Gill K; Fahoury E; Narayanan N; Desai D; Ren J; Nadar R; McElroy T; Moore T; Majeed M; Kalyanam N; Dhanasekaran M
PLoS One; 2021; 16(6):e0252522. PubMed ID: 34081735
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Ongnok B; Chattipakorn N; Chattipakorn SC
Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
